Correlation Between Chemours and Firefly Neuroscience,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chemours and Firefly Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chemours and Firefly Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chemours Co and Firefly Neuroscience,, you can compare the effects of market volatilities on Chemours and Firefly Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chemours with a short position of Firefly Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chemours and Firefly Neuroscience,.

Diversification Opportunities for Chemours and Firefly Neuroscience,

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Chemours and Firefly is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Chemours Co and Firefly Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Firefly Neuroscience, and Chemours is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chemours Co are associated (or correlated) with Firefly Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Firefly Neuroscience, has no effect on the direction of Chemours i.e., Chemours and Firefly Neuroscience, go up and down completely randomly.

Pair Corralation between Chemours and Firefly Neuroscience,

Allowing for the 90-day total investment horizon Chemours Co is expected to under-perform the Firefly Neuroscience,. But the stock apears to be less risky and, when comparing its historical volatility, Chemours Co is 8.84 times less risky than Firefly Neuroscience,. The stock trades about -0.08 of its potential returns per unit of risk. The Firefly Neuroscience, is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  233.00  in Firefly Neuroscience, on December 20, 2024 and sell it today you would earn a total of  249.00  from holding Firefly Neuroscience, or generate 106.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Chemours Co  vs.  Firefly Neuroscience,

 Performance 
       Timeline  
Chemours 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Chemours Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Firefly Neuroscience, 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Firefly Neuroscience, are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Firefly Neuroscience, reported solid returns over the last few months and may actually be approaching a breakup point.

Chemours and Firefly Neuroscience, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chemours and Firefly Neuroscience,

The main advantage of trading using opposite Chemours and Firefly Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chemours position performs unexpectedly, Firefly Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Firefly Neuroscience, will offset losses from the drop in Firefly Neuroscience,'s long position.
The idea behind Chemours Co and Firefly Neuroscience, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals